News | April 27, 2012

Matakina, Commit Agree to Distribute Volpara Breast Density Software in Finland

Volpara Software Designed to Assist Radiologists by Providing Objective Breast Density Values

April 27, 2012 Matakina International Ltd. of Wellington, New Zealand, announced that it has signed a distribution agreement with Commit; Oy of Finland to distribute Volpara to its customer base. The Volpara breast density software works on images from most X-ray vendors and is CE marked and U.S. Food and Drug Administration (FDA) cleared.

“Volpara’s vendor-neutral stance and scientifically proven capability to measure breast density is the key for adoption across whole breast screening programs,” said Ralph Highnam, CEO of Matakina International Ltd. “Inking this deal with Commit allows one of the most preeminent healthcare companies in Finland to give Finnish women the opportunity to start receiving this important breast health information.”

“Commit sees that it is vital to the success in this demanding field to increase quality of work in both image acquisition and also in reading of breast images. Whereas our products to date focus on improving productivity, we are increasingly looking for dedicated tools to increase clinical impact in the overall process,” said Markku Myllylä, CEO of Commit; Oy.

Breast tissue density has not only been linked to an increased risk of breast cancer, it also decreases the sensitivity of the mammogram and thereby may impact early detection.  Several large studies have confirmed that as tissue density increases, the accuracy of mammography decreases. Thirty-five percent of breast cancer goes undetected by mammography in women with dense breasts, as density masks the appearance of tumors (Boyd et al 2007, NEJM). Since both dense breast tissue and cancer appear white on a mammogram, finding cancers can be analogous to looking for a snowball in a snowstorm.

The Volpara breast imaging software computes volumetric breast tissue density from digital mammograms, providing radiologists a reliable tool to automatically generate objective volumetric breast density values. The software also assists radiologists by providing an objective, automatic measurement of volumetric breast tissue density and provides the Volpara Density Grade that is correlated with the American College of Radiology BIRADS Density Grading Classifications. Volpara integrations with other digital mammography systems, computer-aided detection (CAD) systems and mammography reporting system are also under way.

Related Content

Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...
Ikonopedia Introduces Automated Combined Reporting Package at SBI
News | Mammography Reporting Software | April 04, 2019
Ikonopedia will introduce its new Automated Combined Reporting package at the 2019 Society of Breast Imaging/American...
Konica Minolta Highlights New Exa Mammo Features at SBI/ACR Breast Imaging Symposium
News | Breast Imaging | April 03, 2019
Konica Minolta Healthcare Americas Inc. will highlight new features of Exa Mammo, a picture archiving and communication...
A smart algorithm developed by iCAD

A smart algorithm developed by iCAD outlines and scores a suspicious lesion seen in an image created using digital breast tomography. Displayed is the probability calculated by the algorithm that the outlined area includes a cancerous lesion. Image courtesy of Emily Conant, M.D.

Feature | Artificial Intelligence | April 03, 2019 | Greg Freiherr
  Editor's Note: This article was updated following the SBI symposium.  
Lunit Showcases AI Solution for Breast Cancer at SBI 2019
News | Artificial Intelligence | April 02, 2019
Medical artificial intelligence (AI) startup Lunit announced its attendance at the Society of Breast Imaging (SBI) 2019...